These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 13696125)

  • 1. Immunization against poliomyelitis with a trivalent oral vaccine.
    COX HR; CABASSO VJ; EMBIL J; MARKHAM FS; MOSES MJ; MOYER AW; ROCA-GARCIA M; RUEGSEGGER JM
    Pathol Microbiol (Basel); 1961; 24(Suppl)():61-72. PubMed ID: 13696125
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunization of newborn infants with antipoliomyelitis trivalent oral vaccine].
    CAMPILLO SAINZ C; ORNELAS HERNANDEZ A; DE MUCHA MACIAS J; NAVA SE
    Bol Oficina Sanit Panam; 1962 Aug; 53():130-5. PubMed ID: 13876085
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anti-poliomyelitis vaccination with inactivated virus (Lepine vaccine). Effect of the booster injection on immunization].
    MARTIN R; ROGER F; DAMAS JP; ROGER A; JUILLARD P
    Bull Acad Natl Med; 1961 Nov 21-28; 145():664-73. PubMed ID: 14470436
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunization of infants with formalinized poliomyelitis vaccine (Salk type).
    SPIGLAND I; GOLDBLUM N
    Pediatrics; 1960 May; 25():812-21. PubMed ID: 13833339
    [No Abstract]   [Full Text] [Related]  

  • 5. Response of infants to a third dose of poliomyelitis vaccine given 10 to 12 months after primary immunization.
    PERKINS FT; YETTS R; GAISFORD W
    Br Med J; 1959 Mar; 1(5123):680-2. PubMed ID: 13629087
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunization with live polio vaccine].
    VODOPIJA I
    Lijec Vjesn; 1962 Jun; 84():545-51. PubMed ID: 13926382
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antibody response of infants to a "booster" dose of the Salk type of poliomyelitis vaccine given from 5 to 6 months after early primary immunization].
    MORRONE G; NUNZIATA B
    Pediatria (Napoli); 1961; 69():851-6. PubMed ID: 14476315
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunization of man against poliomyelitis with attenuated preparations of living virus.
    KOPROWSKI H
    Ann N Y Acad Sci; 1955 Sep; 61(4):1039-49. PubMed ID: 13340613
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of aluminum hydroxide on the immunizing properties of inactivated poliomyelitis vaccine].
    HAAS R; DOSTAL V; SAUTHOFF R
    Klin Wochenschr; 1955 Dec; 33(45-46):1082-4. PubMed ID: 13287015
    [No Abstract]   [Full Text] [Related]  

  • 10. The relationship between specific skin reaction and neutralizing antibody titers in the young infant following immunization with poliomyelitis (Salk-type) vaccine.
    MORRONE G; NUNZIATA B
    Ann Paediatr; 1961; 196():389-98. PubMed ID: 13772899
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on combined adsorbed poliomyelitis-DTP vaccine. Poliomyelitis antibody responses of children to primary immunization.
    HALONEN P; KAUHTIO J; LAMY M; LAPINLEIMU K; PENTTINEN K; PERHEENTUPA J; TAMMILEHTO R; TORNBLOM N
    Acta Paediatr (Stockh); 1962 Jul; 51():409-16. PubMed ID: 13903980
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serological response of a group of infants and adults to antipoliomyelitis vaccination with the Cox trivalent oral vaccine].
    LIPPI M; SEBASTIANI A; FRUGONI G
    Ann Inst Pasteur (Paris); 1961 Sep; 101():318-26. PubMed ID: 14465729
    [No Abstract]   [Full Text] [Related]  

  • 13. [Observations on the immunizing effect of small doses of poliomyelitis vaccine inoculated by intradermal route in adult subjects].
    ROSA A; LA PLACA M
    Riv Ital Ig; 1959; 19():143-8. PubMed ID: 14438768
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antipoliomyelitic vaccination in the infant. Study of simple immunization and immunization by vaccine combinations].
    GRUMBACH R; ROGER F; AYMARD B
    Sem Hop Ther Paris; 1960 Jul; 36():591-9. PubMed ID: 13829843
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mass vaccination against poliomyelitis with a trivalent vaccine containing attenuated live viruses].
    FERREIRA E
    J Pediatr (Rio J); 1962 Mar; 27():94-109. PubMed ID: 13892533
    [No Abstract]   [Full Text] [Related]  

  • 16. [The formation of neutralizing antibodies in humans after poliomyelitis immunization with the Behring vaccine].
    KELLER W; SAUTHOFF R
    Dtsch Med Wochenschr; 1955 Sep; 80(37):1329-31. PubMed ID: 13261706
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of the immunization in various age groups with live poliomyelitis vaccines in 1960].
    WELKE G; STARKE G
    Dtsch Gesundheitsw; 1961 Jun; 16():1165-7. PubMed ID: 13784204
    [No Abstract]   [Full Text] [Related]  

  • 18. [2 1/2 Years of antipoliomyelitis vaccination (Lepine vaccine) at the Institut Pasteur hospital. Immunological results. Significance of the booster injection].
    MARTIN R; ROGER F; DAMAS JP; ROGER A
    Ann Inst Pasteur (Paris); 1959 Dec; 97():757-79. PubMed ID: 14421731
    [No Abstract]   [Full Text] [Related]  

  • 19. Present position of immunization against poliomyelitis with live virus vaccines.
    SABIN AB
    Br Med J; 1959 Mar; 1(5123):663-80. PubMed ID: 13629086
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of mass oral immunization with live vaccine prepared from Sabin's strain on epidemiological processes in poliomyelitis].
    CUMAKOV MP
    Cesk Epidemiol Mikrobiol Imunol; 1960 Jul; 9():406-7. PubMed ID: 13813269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.